{"gene":"RIC3","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2002,"finding":"C. elegans RIC-3 is specifically required for the maturation (folding/assembly and proper trafficking) of at least four nicotinic acetylcholine receptors (nAChRs), but not GABA or glutamate receptors expressed in the same cells. In ric-3 mutants, the DEG-3 receptor accumulates in the cell body rather than cell processes. Co-expression of ric-3 in Xenopus oocytes enhances activity of DEG-3/DES-2 and rat α7 nAChRs, demonstrating functional conservation.","method":"Genetic loss-of-function (C. elegans ric-3 mutants), immunolocalization, Xenopus oocyte co-expression electrophysiology","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vivo genetics, localization, heterologous expression), replicated in subsequent studies","pmids":["11867529"],"is_preprint":false},{"year":2003,"finding":"Human RIC-3 (hRIC-3) belongs to a conserved gene family (two transmembrane domains + coiled-coil domain) and differentially modulates human nAChRs: it enhances α7 nAChR currents but reduces α4β2 and α3β4 nAChR currents, and totally abolishes 5-HT3 receptor currents while barely affecting α1 glycine receptor currents in Xenopus oocytes. hRIC-3 produces multiple isoforms and is expressed in neurons and muscles.","method":"Xenopus oocyte co-expression with whole-cell current recording, RT-PCR/expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional electrophysiology across multiple receptor subtypes, independently replicated by subsequent papers","pmids":["12821669"],"is_preprint":false},{"year":2004,"finding":"RIC-3 promotes formation of functional α7 nAChRs in mammalian HEK293 cells, as shown by whole-cell patch clamp and surface α-bungarotoxin binding. α7 and RIC-3 proteins co-associate by co-immunoprecipitation. RIC-3 enables α-bungarotoxin surface labeling even though α7 protein reaches the plasma membrane without RIC-3, indicating RIC-3 is required for proper folding/assembly (not merely trafficking) of α7 receptors.","method":"Whole-cell patch clamp, surface biotinylation, α-bungarotoxin binding, co-immunoprecipitation in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional and biochemical evidence in mammalian cells, replicated across labs","pmids":["15504725"],"is_preprint":false},{"year":2005,"finding":"RIC-3 enhances functional expression of multiple homomeric (α7, α8) nAChR subtypes in transfected mammalian cells. Unlike in Xenopus oocytes, RIC-3 also enhances heteromeric nAChRs (α3β2, α3β4, α4β2, α4β4) in mammalian cells. Co-immunoprecipitation demonstrates RIC-3 associates with unassembled nAChR subunits (α3, α4, α7, β2, β4), consistent with a role in promoting subunit folding and assembly.","method":"Radioligand binding, patch clamp electrophysiology, co-immunoprecipitation from metabolically labeled transfected mammalian cells","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple receptor subtypes, orthogonal methods (binding + function + co-IP), independently replicated","pmids":["16120769"],"is_preprint":false},{"year":2005,"finding":"hRIC-3 inhibits surface expression of α4β2 nAChRs and 5-HT3 receptors by blocking export of mature receptors to the cell membrane, whereas it enhances α7 nAChR expression by increasing the number of mature receptors and facilitating membrane transport. The N-terminal region (two TM segments) and C-terminal region are both required for these differential effects. A specific extracellular isoleucine near the first TM domain of 5-HT3/α4β2 receptors mediates the transport arrest induced by hRIC-3. Specific amino acids in the amphipathic helix of the large cytoplasmic domain of α7 are required for enhancement.","method":"Chimeric receptor co-expression, site-directed mutagenesis, co-immunoprecipitation, confocal microscopy in Xenopus oocytes and mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of specific residues combined with functional and trafficking assays, multiple orthogonal approaches","pmids":["15927954"],"is_preprint":false},{"year":2005,"finding":"RIC-3 is localized to the endoplasmic reticulum (co-localization with BiP). RIC-3 enhances surface transport and function of 5-HT3A receptors in a concentration-dependent manner. The interaction between RIC-3 and 5-HT3A is transient (<4 h). RIC-3 can interact with an ER-retained 5-HT3A construct, suggesting a role in folding/assembly rather than later trafficking steps. RIC-3 is not detected at significant levels on the cell surface.","method":"Confocal co-localization with BiP (ER marker), co-immunoprecipitation time course, surface expression assays in mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct co-IP evidence for transient interaction, ER localization confirmed biochemically and by co-localization, multiple orthogonal methods","pmids":["15809299"],"is_preprint":false},{"year":2005,"finding":"RIC-3 effects on DEG-3/DES-2 nAChR functional expression and receptor kinetics/agonist affinity are mediated by the transmembrane domains and do not require the coiled-coil domains. RIC-3 preferentially promotes maturation of DEG-3-rich receptors, affecting the subunit composition of assembled receptors. RIC-3 also stabilizes receptor intermediates (affects DEG-3 quantity).","method":"Xenopus oocyte co-expression electrophysiology, deletion/domain-swap mutagenesis, receptor subunit ratio manipulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — domain mutagenesis with functional readout, multiple receptor ratios tested, single lab","pmids":["15932871"],"is_preprint":false},{"year":2007,"finding":"Human RIC-3 isoform a (RIC-3a) is targeted to the ER by an N-terminal signal sequence and forms diffuse reticular and halo structures; it is highly mobile within the ER. RIC-3a enhances surface expression of homomeric 5-HT3A receptors but inhibits surface expression of heteromeric 5-HT3A/B receptors. A truncated isoform (RIC-3d), lacking the large coiled-coil C-terminal domain, localizes to ER and cycles between ER and Golgi, does not aggregate, yet retains the ability to enhance homomeric and inhibit heteromeric 5-HT3 receptor surface expression.","method":"Fluorescence live imaging (FRAP), confocal co-localization, flow cytometry surface expression assays in mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — live imaging with FRAP, subcellular fractionation, multiple receptor readouts, single lab but multiple orthogonal methods","pmids":["17609200"],"is_preprint":false},{"year":2007,"finding":"hRIC-3 membrane topology: in vitro translation showed membrane insertion but the first TM domain does not act as a signal peptide. Substitution of both TM domains attenuates effects on nAChR expression. A minimum linker length between TM domains is needed for α7 enhancement but not for α4β2 inhibition. A combination of increased α7 steady-state levels, facilitated transport, and reduced receptor internalization accounts for hRIC-3-mediated enhancement of α7 membrane expression. RIC-3 is expressed in SH-SY5Y and PC12 cells and is induced upon differentiation; immunohistochemistry localizes it to rat brain regions co-expressing α7 nAChRs.","method":"In vitro translation/membrane insertion assay, TM domain substitution mutagenesis, immunohistochemistry, Western blot","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with functional assays and localization, single lab","pmids":["18179477"],"is_preprint":false},{"year":2008,"finding":"The coiled-coil domain (CC-I) of C. elegans RIC-3 mediates receptor-specific interactions: it promotes maturation of specific nAChRs expressed in body-wall muscle but is dispensable for other nAChR subtypes. Co-immunoprecipitation confirms CC-I enhances RIC-3 affinity for specific nAChRs. Alternative splicing generates RIC-3 isoforms lacking CC-I or the entire C-terminus, enabling subtype-specific regulation.","method":"In vivo C. elegans deletion mutant analysis, co-immunoprecipitation, Xenopus oocyte heterologous expression electrophysiology","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetics combined with co-IP and heterologous expression, multiple receptor subtypes tested","pmids":["19116311"],"is_preprint":false},{"year":2008,"finding":"Drosophila RIC-3 nAChR chaperone activity does not require the coiled-coil domain (encoded by exon 7). An extra exon (exon 2) within a proline-rich N-terminal region greatly reduces chaperone activity. Host-cell-specific factors modulate RIC-3 chaperone efficiency: DmRIC-3 is more efficient in Drosophila cells, whereas human RIC-3 is more efficient in human cells, indicating cell-type-specific modulatory proteins.","method":"Cloning of 11 alternative splice isoforms, co-expression electrophysiology in Drosophila and human cell lines","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional comparison across isoforms and cell types, single lab, single functional readout","pmids":["18208544"],"is_preprint":false},{"year":2009,"finding":"Mouse RIC-3 is targeted to the ER by a cleavable N-terminal signal sequence (first 31 aa). The mature protein is a single-pass type I transmembrane protein with the N-terminus in the ER lumen and the coiled-coil domain in the cytoplasm. RIC-3 binds both unfolded and folded α7 subunits. The coiled-coil domain is required for homotypic self-association of RIC-3 molecules, which is necessary for efficient α7 assembly, but the coiled-coil is not required for RIC-3–α7 interaction itself. The lumenal segment and the coiled-coil domain (but not the long C-terminal tail) are required for facilitating α7 surface expression.","method":"Signal sequence analysis, protease protection/topology assay, co-immunoprecipitation, deletion/domain mutagenesis, surface expression assays in mammalian cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — topology determination, mutagenesis of multiple domains, binding to folded vs unfolded subunits distinguished, multiple orthogonal assays","pmids":["19812337"],"is_preprint":false},{"year":2009,"finding":"BATH-42, a BTB-MATH domain-containing protein, interacts with RIC-3 (shown in yeast two-hybrid and in vitro). BATH-42 also interacts with the CUL-3 ubiquitin ligase complex. Loss of BATH-42 increases RIC-3 expression and decreases nAChR activity; overexpression of BATH-42 is also detrimental in a CUL-3-dependent and RIC-3 C-terminus-dependent manner. The data indicate BATH-42 targets RIC-3 for degradation via CUL-3-mediated ubiquitylation, thereby regulating RIC-3 levels.","method":"Yeast two-hybrid, in vitro interaction assay, C. elegans genetic loss-of-function/overexpression, electrophysiology","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vitro interaction plus in vivo genetic epistasis, multiple orthogonal methods","pmids":["19223395"],"is_preprint":false},{"year":2009,"finding":"Conserved residues in the second RIC-3 transmembrane domain are required for interactions with DEG-3/DES-2 and ACR-16 nAChRs, but additional domains also contribute. The relative contribution of the second TM domain vs. other domains differs between the two receptors, suggesting RIC-3 (predicted intrinsically disordered) adopts different conformations to interact with different receptors/subunits.","method":"Co-immunoprecipitation with domain deletion/point mutants in C. elegans and Xenopus oocytes, surface expression assays","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with co-IP and functional assays, single lab","pmids":["19899809"],"is_preprint":false},{"year":2010,"finding":"Ric-3 can promote OR inhibit cell-surface delivery of α7 nAChRs (BgtRs) depending on expression level. At low levels, Ric-3 promotes α7 assembly, ER release, and surface delivery without trafficking from the ER itself. At high levels, Ric-3 suppresses surface delivery but not assembly, retaining BgtRs in the ER or in Ric-3-containing aggregates. In neurons, Ric-3 and α7 subunits are restricted to somata and dendrites (not axons) of inhibitory interneurons; Ric-3 traffics with α7 in vesicles to dendrites where it is restricted to the ER subcompartment, suggesting ER retention promotes dendritic transport.","method":"PC12 and cultured neuron live imaging, immunolocalization, co-trafficking experiments, surface BgtR binding assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — live imaging in neurons with trafficking analysis, multiple cell types, functional and localization readouts combined","pmids":["20668195"],"is_preprint":false},{"year":2010,"finding":"RIC-3 directly interacts with 5-HT3A, -C, -D, and -E subunits (co-localization in ER and co-immunoprecipitation), but exclusively enhances surface expression of homomeric 5-HT3A receptors in HEK293 cells. Increases in functional response (Emax) correlate with increased surface receptor levels (Bmax for [3H]GR65630 binding) and increased surface 5-HT3A as measured by flow cytometry.","method":"Co-immunoprecipitation, co-localization by immunocytochemistry, Ca2+ influx assays, radioligand binding, flow cytometry in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP interaction with multiple subunits combined with functional assays and flow cytometry, multiple orthogonal methods","pmids":["20522555"],"is_preprint":false},{"year":2013,"finding":"RIC-3 increases assembly and cell-surface trafficking of α7 receptors but does not alter α7 protein expression levels in HEK293T cells. In contrast, RIC-3 does not affect α4β2 receptor assembly but increases α4 and β2 subunit protein expression. When co-expressed with α4β2 receptors, RIC-3 prevents nicotine-induced upregulation of α4β2 receptors (assessed by FRET between subunits).","method":"FRET microscopy with fluorescent protein-tagged subunits, surface trafficking assays in HEK293T cells","journal":"BMC neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET-based assembly measurement, single lab, two receptor subtypes compared","pmids":["23586521"],"is_preprint":false},{"year":2016,"finding":"Phosphorylation of RIC-3 at Ser-164 in C. elegans increases muscle excitability. This phosphorylation is regulated by the phosphatase calcineurin (TAX-6) and casein kinase II homologue KIN-10. Effects of calcineurin downregulation and phosphorylated RIC-3 on excitability are mediated by GABAA receptor inhibition. Thus, phosphorylated RIC-3 influences not only nAChRs but also GABAA receptors, enabling coordinated regulation of excitation-inhibition balance.","method":"C. elegans in vivo phosphorylation analysis, genetic epistasis with calcineurin and casein kinase II mutants, electrophysiology","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetics with epistasis and specific phosphorylation site identified, single lab","pmids":["27489343"],"is_preprint":false},{"year":2016,"finding":"RIC-3 expression level and splicing (generating multiple conserved isoforms) affect nAChR functional expression in brain and immune cells. In immune cells, RIC-3 expression and splicing are dynamically regulated by inflammatory signals. siRNA-mediated silencing of RIC3 in mouse macrophages eliminates the anti-inflammatory effects of cholinergic agonists, placing RIC3 as required for functional α7 nAChR-mediated cholinergic anti-inflammatory signaling.","method":"In situ hybridization, qRT-PCR, Xenopus oocyte electrophysiology, siRNA knockdown in macrophages with functional anti-inflammatory readout","journal":"Molecular brain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with specific functional readout in immune cells, combined with expression analysis, single lab","pmids":["27129882"],"is_preprint":false},{"year":2016,"finding":"Two RIC3 missense variants (P57T and V168L) identified in Parkinson's disease patients act as dominant negatives in PC12 cells: they reduce endogenous CHRNA7 (α7 nAChR subunit) levels in membrane fractions and decrease co-localization profiles compared to wild-type RIC3, suggesting impaired chaperone-mediated receptor trafficking to the plasma membrane.","method":"Transfection of mutant RIC3 in differentiated PC12 cells, Western blot of membrane fractions, confocal co-localization","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based dominant negative assay with biochemical and imaging readouts, single lab","pmids":["27055476"],"is_preprint":false},{"year":2019,"finding":"The intracellular domain (ICD) of 5-HT3A is required for its interaction with RIC-3. A 24-amino-acid-long segment within the 5-HT3A ICD is the molecular determinant for the RIC-3–5-HT3A interaction, identified using MBP-fused ICD deletion constructs in a RIC-3 affinity pull-down assay.","method":"Recombinant MBP-fused 5-HT3A ICD deletion constructs, RIC-3 affinity pull-down assay with purified proteins","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro pull-down with purified recombinant proteins and deletion constructs, single lab","pmids":["31870537"],"is_preprint":false},{"year":2023,"finding":"Two residues in nematode ACR-16 nAChR (R/K159 in the cys-loop and I504 in the C-terminal tail) account for the receptor's requirement for RIC-3 in functional expression. Mutating either residue in a non-RIC-3-requiring ACR-16 (from Dracunculus medinensis) to residues found in RIC-3-requiring orthologs confers a RIC-3 requirement, demonstrating these receptor residues mediate the functional dependency on RIC-3.","method":"Chimeric receptor construction, point mutagenesis, electrophysiology in Xenopus oocytes","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reciprocal mutagenesis in chimeric receptors with gain-of-function phenotype, electrophysiological readout, single lab","pmids":["37417463"],"is_preprint":false},{"year":2023,"finding":"The RIC-3 binding motif in 5-HT3A is a duplicated sequence (DWLR…VLDR) present in both the MX-helix and the transition between the ICD MA-helix and TM segment M4. Key residues W347, R349, L353 (MX-helix) and W447, R449, L454 (MAM4 transition) are critical for RIC-3 interaction. Alanine substitutions at these positions disrupt both peptide-based and full-length 5-HT3A–RIC-3 interactions and reduce RIC-3-mediated enhancement of functional surface expression.","method":"Ala-scanning mutagenesis with synthetic peptides in pull-down assay, full-length receptor mutagenesis with surface expression functional assays","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic Ala-scanning of binding motif validated in both peptide and full-length receptor contexts, single lab","pmids":["37026993"],"is_preprint":false},{"year":2024,"finding":"A RIC3 variant G88R associated with exceptional backward speech decreases both cell-surface expression and functional expression of α7 nAChRs compared to wild-type RIC3. FRET analysis shows that RIC3-G88R increases interactions between RIC3 and α7 protein in the ER, suggesting excessive or prolonged ER retention underlies reduced surface expression.","method":"FRET microscopy with fluorescent protein-tagged α7 nAChR, 125I-α-bungarotoxin binding, functional assays in HEK cells","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET combined with binding and functional assays, single lab, single variant studied","pmids":["38472514"],"is_preprint":false},{"year":2026,"finding":"RIC-3 directly interacts with the 5-HT3A intracellular domain (ICD) in native cellular contexts: a recombinant 5-HT3A ICD peptide specifically pulls down RIC-3 from Xenopus oocyte plasma membrane fractions, SH-SY5Y cell ER fractions, and mouse brain tissue. RIC-3 knockdown in SH-SY5Y cells reduces both this peptide binding and surface levels of nAChR-α7 and 5-HT3A receptors.","method":"Peptide-resin pull-down assay from native tissue and cell fractions, RIC-3 siRNA knockdown with surface receptor quantification","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pull-down from native contexts is compelling but preprint, single lab, not yet peer-reviewed","pmids":["41756857"],"is_preprint":true}],"current_model":"RIC-3 is an ER-resident single-pass transmembrane protein (with a cleavable signal sequence directing its N-terminus into the ER lumen and a cytoplasmic coiled-coil domain) that acts as a subtype-specific molecular chaperone for pentameric ligand-gated ion channels: at physiological levels it transiently binds unassembled nAChR and 5-HT3 receptor subunits via its transmembrane domains and specific receptor ICD motifs (including a duplicated DWLR/VLDR motif in 5-HT3A), promoting subunit folding, oligomeric assembly, and ER export primarily for homomeric α7 nAChRs and homomeric 5-HT3A receptors, while retaining or inhibiting maturation of heteromeric subtypes (α4β2, α3β4, 5-HT3A/B); its chaperone activity is dose-dependent (high levels cause ER retention), regulated by CUL-3-mediated ubiquitylation (via BATH-42) and by phosphorylation at Ser-164 (controlled by calcineurin/casein kinase II balance), and modulated by alternative splicing that generates isoforms with differential subcellular distributions and receptor-subtype specificities."},"narrative":{"mechanistic_narrative":"RIC-3 is an endoplasmic reticulum-resident transmembrane chaperone that controls the folding, assembly, and surface delivery of pentameric ligand-gated ion channels, principally nicotinic acetylcholine receptors (nAChRs) and 5-HT3 receptors [PMID:11867529, PMID:12821669, PMID:15809299]. Identified in C. elegans as specifically required for maturation of multiple nAChRs but not GABA or glutamate receptors [PMID:11867529], it acts subtype-selectively: it enhances functional expression of homomeric receptors such as α7, α8, and homomeric 5-HT3A, while inhibiting or retaining heteromeric subtypes including α4β2, α3β4, and 5-HT3A/B [PMID:12821669, PMID:16120769, PMID:17609200, PMID:20522555]. Co-immunoprecipitation establishes that RIC-3 transiently and directly binds unassembled receptor subunits in the ER to promote proper folding and oligomeric assembly rather than acting only at later trafficking steps [PMID:15504725, PMID:16120769, PMID:15809299]. Topologically it is a single-pass type I transmembrane protein with a cleavable N-terminal signal sequence placing its N-terminus in the ER lumen and its coiled-coil domain in the cytoplasm; the transmembrane domains mediate receptor binding, while coiled-coil-dependent self-association drives efficient α7 assembly [PMID:19812337, PMID:19899809]. Receptor specificity is encoded on both partners: RIC-3 recognizes intracellular-domain motifs in 5-HT3A—a duplicated DWLR/VLDR sequence in the MX-helix and MA-helix/M4 transition [PMID:31870537, PMID:37026993]—and discrete receptor residues (e.g., in ACR-16) dictate the dependency on RIC-3 [PMID:37417463]. RIC-3 chaperone activity is dose-dependent, switching from promoting surface delivery at low levels to ER retention and aggregation at high levels [PMID:20668195], and is further controlled by CUL-3/BATH-42-mediated ubiquitylation that sets RIC-3 protein levels [PMID:19223395] and by Ser-164 phosphorylation under calcineurin/casein kinase II control, which extends its influence to excitation-inhibition balance via GABAA receptors [PMID:27489343]. Functionally, RIC-3 is required for α7 nAChR-mediated cholinergic anti-inflammatory signaling in macrophages [PMID:27129882], and RIC3 missense variants that impair α7 trafficking have been linked to Parkinson's disease and to an exceptional-backward-speech phenotype [PMID:27055476, PMID:38472514].","teleology":[{"year":2002,"claim":"Established RIC-3 as a dedicated maturation factor for nAChRs, answering whether a specific accessory protein governs nicotinic receptor biogenesis distinct from other ionotropic receptors.","evidence":"C. elegans ric-3 loss-of-function genetics, immunolocalization of DEG-3, and Xenopus oocyte co-expression electrophysiology","pmids":["11867529"],"confidence":"High","gaps":["Did not define the molecular mechanism of action (folding vs trafficking)","Did not establish subcellular site of action","Mammalian receptor scope untested at this stage"]},{"year":2003,"claim":"Demonstrated that the human ortholog is subtype-selective, showing RIC-3 can enhance some channels (α7) while suppressing others (α4β2, α3β4, 5-HT3), establishing differential modulation as a core feature.","evidence":"Xenopus oocyte co-expression whole-cell recording across multiple receptor subtypes plus expression analysis","pmids":["12821669"],"confidence":"High","gaps":["Mechanism of opposite effects on different subtypes unexplained","Domain requirements undefined","Oocyte results later found to differ from mammalian cells"]},{"year":2004,"claim":"Showed RIC-3 physically associates with α7 and is required for folding/assembly rather than mere trafficking, since α7 reaches the surface without RIC-3 but is not functional.","evidence":"Whole-cell patch clamp, surface biotinylation, α-bungarotoxin binding and co-immunoprecipitation in HEK293 cells","pmids":["15504725"],"confidence":"High","gaps":["Did not identify the interacting domains","Stoichiometry and transience of binding unresolved"]},{"year":2005,"claim":"Localized RIC-3 to the ER and defined its action as transient binding to unassembled/ER-retained subunits, fixing the cellular site and timing of chaperone activity; also mapped which receptor and RIC-3 regions drive enhancement vs transport arrest.","evidence":"BiP co-localization, co-IP time courses, chimeric receptor and site-directed mutagenesis, and domain analyses in mammalian cells and oocytes","pmids":["15809299","15927954","16120769","15932871"],"confidence":"High","gaps":["Precise binding motifs not yet defined","Membrane topology not established","Discrepancy between oocyte and mammalian heteromer effects unexplained"]},{"year":2009,"claim":"Resolved RIC-3 membrane topology and the division of labor among its domains, establishing that TM domains mediate receptor binding while the coiled-coil drives self-association required for efficient α7 assembly.","evidence":"Signal-sequence and protease-protection topology assays, deletion/domain mutagenesis, and co-IP distinguishing folded vs unfolded α7 binding in mammalian cells","pmids":["19812337","19116311","19899809"],"confidence":"High","gaps":["Conformational basis for binding diverse receptors not structurally defined","Self-association stoichiometry unknown"]},{"year":2009,"claim":"Identified post-translational control of RIC-3 abundance, showing BATH-42 links RIC-3 to CUL-3-mediated ubiquitylation and degradation to tune chaperone levels.","evidence":"Yeast two-hybrid, in vitro interaction, and C. elegans genetic epistasis with electrophysiology","pmids":["19223395"],"confidence":"High","gaps":["Ubiquitylation sites on RIC-3 not mapped","Conservation of this regulation in mammals untested"]},{"year":2010,"claim":"Demonstrated that RIC-3 effects are concentration-dependent, switching from promoting surface delivery at low levels to ER retention/aggregation at high levels, reconciling its dual enhancing/inhibitory behavior.","evidence":"Live imaging and co-trafficking in PC12 cells and neurons with surface α-bungarotoxin binding","pmids":["20668195"],"confidence":"High","gaps":["Physiological control of RIC-3 dosage in vivo unclear","Relationship of aggregation to dendritic targeting mechanistically incomplete"]},{"year":2016,"claim":"Extended RIC-3 regulation to phosphorylation, showing Ser-164 phosphorylation under calcineurin/CKII control modulates excitability and broadens its influence to GABAA receptors.","evidence":"C. elegans in vivo phosphorylation analysis and genetic epistasis with electrophysiology","pmids":["27489343"],"confidence":"Medium","gaps":["Direct phosphorylation of RIC-3 by these kinases not biochemically shown","Mammalian conservation of Ser-164 regulation untested"]},{"year":2016,"claim":"Linked RIC-3 to physiological cholinergic signaling beyond neurons, establishing it as required for α7 nAChR-mediated anti-inflammatory responses in immune cells.","evidence":"siRNA knockdown in macrophages with cholinergic anti-inflammatory functional readout plus expression/splicing analysis","pmids":["27129882"],"confidence":"Medium","gaps":["Mechanism of inflammatory regulation of RIC3 splicing unresolved","Single functional readout"]},{"year":2019,"claim":"Mapped the 5-HT3A determinant of RIC-3 binding to a discrete 24-residue intracellular-domain segment, moving receptor recognition from region-level to motif-level resolution.","evidence":"MBP-fused ICD deletion constructs in RIC-3 affinity pull-down with purified proteins","pmids":["31870537"],"confidence":"Medium","gaps":["Performed with purified fragments rather than full-length receptor in cells","Single lab"]},{"year":2023,"claim":"Defined RIC-3 recognition on both partners at residue resolution: a duplicated DWLR/VLDR motif in the 5-HT3A ICD and specific ACR-16 residues that confer dependency on RIC-3.","evidence":"Ala-scanning of synthetic peptides and full-length receptors with functional surface assays; reciprocal chimeric/point mutagenesis with oocyte electrophysiology","pmids":["37026993","37417463"],"confidence":"High","gaps":["Structure of the RIC-3–receptor complex not solved","Whether the same motifs govern nAChR binding broadly untested"]},{"year":2024,"claim":"Connected RIC3 sequence variation to human phenotypes, showing disease-associated variants impair α7 surface delivery through aberrant ER retention or dominant-negative trafficking defects.","evidence":"FRET, 125I-α-bungarotoxin binding, and functional assays of variant RIC3 in PC12/HEK cells","pmids":["38472514","27055476"],"confidence":"Medium","gaps":["Causality in patients not established by family/rescue studies in the corpus","Single variants studied per phenotype"]},{"year":null,"claim":"How RIC-3 structurally accommodates and discriminates among diverse receptor subunits to produce opposite (enhancing vs retaining) outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of a RIC-3–receptor complex","Molecular basis for subtype-selective enhancement vs retention unexplained","Mammalian counterparts of BATH-42/CUL-3 and Ser-164 regulation not identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,2,3,5,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,14]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,7,11,14]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,3,5,11]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[4,14,15]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,8,14]}],"complexes":[],"partners":["CHRNA7","HTR3A","BATH-42","CUL-3","CHRNB2","CHRNA4","DEG-3","ACR-16"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q7Z5B4","full_name":"Protein RIC-3","aliases":["Resistant to inhibitor of cholinesterase 3"],"length_aa":369,"mass_kda":41.1,"function":"Molecular chaperone which facilitates proper subunit assembly and surface trafficking of alpha-7 (CHRNA7) and alpha-8 (CHRNA8) nicotinic acetylcholine receptors (PubMed:12821669, PubMed:15504725, PubMed:16120769, PubMed:18691158, PubMed:32204458). May also promote functional expression of homomeric serotoninergic 5-HT3 receptors, and of heteromeric acetylcholine receptors alpha-3/beta-2, alpha-3/beta-4, alpha-4/beta-2 and alpha-4/beta-4","subcellular_location":"Endoplasmic reticulum membrane; Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q7Z5B4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RIC3","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RIC3","total_profiled":1310},"omim":[{"mim_id":"610509","title":"RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE; RIC3","url":"https://www.omim.org/entry/610509"},{"mim_id":"168600","title":"PARKINSON DISEASE, LATE-ONSET; PD","url":"https://www.omim.org/entry/168600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RIC3"},"hgnc":{"alias_symbol":["FLJ11608","PRO1385","AYST720"],"prev_symbol":[]},"alphafold":{"accession":"Q7Z5B4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z5B4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z5B4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z5B4-F1-predicted_aligned_error_v6.png","plddt_mean":57.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RIC3","jax_strain_url":"https://www.jax.org/strain/search?query=RIC3"},"sequence":{"accession":"Q7Z5B4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z5B4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z5B4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z5B4"}},"corpus_meta":[{"pmid":"11867529","id":"PMC_11867529","title":"The C. elegans ric-3 gene is required for maturation of nicotinic acetylcholine receptors.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11867529","citation_count":203,"is_preprint":false},{"pmid":"12821669","id":"PMC_12821669","title":"Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12821669","citation_count":160,"is_preprint":false},{"pmid":"15504725","id":"PMC_15504725","title":"Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15504725","citation_count":137,"is_preprint":false},{"pmid":"16120769","id":"PMC_16120769","title":"RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.","date":"2005","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16120769","citation_count":131,"is_preprint":false},{"pmid":"18246096","id":"PMC_18246096","title":"RIC-3: a nicotinic acetylcholine receptor chaperone.","date":"2008","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18246096","citation_count":104,"is_preprint":false},{"pmid":"15927954","id":"PMC_15927954","title":"Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15927954","citation_count":87,"is_preprint":false},{"pmid":"15809299","id":"PMC_15809299","title":"Cell surface expression of 5-hydroxytryptamine type 3 receptors is promoted by RIC-3.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15809299","citation_count":61,"is_preprint":false},{"pmid":"18208544","id":"PMC_18208544","title":"Host-cell specific effects of the nicotinic acetylcholine receptor chaperone RIC-3 revealed by a comparison of human and Drosophila RIC-3 homologues.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18208544","citation_count":51,"is_preprint":false},{"pmid":"20668195","id":"PMC_20668195","title":"Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20668195","citation_count":43,"is_preprint":false},{"pmid":"17609200","id":"PMC_17609200","title":"Differential subcellular localization of RIC-3 isoforms and their role in determining 5-HT3 receptor composition.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17609200","citation_count":41,"is_preprint":false},{"pmid":"27573666","id":"PMC_27573666","title":"Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.","date":"2017","source":"Central nervous system agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27573666","citation_count":40,"is_preprint":false},{"pmid":"18956371","id":"PMC_18956371","title":"RIC-3 and nicotinic acetylcholine receptors: biogenesis, properties, and diversity.","date":"2008","source":"Biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/18956371","citation_count":39,"is_preprint":false},{"pmid":"19812337","id":"PMC_19812337","title":"Mouse RIC-3, an endoplasmic reticulum chaperone, promotes assembly of the alpha7 acetylcholine receptor through a cytoplasmic coiled-coil domain.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19812337","citation_count":39,"is_preprint":false},{"pmid":"15932871","id":"PMC_15932871","title":"RIC-3 affects properties and quantity of nicotinic acetylcholine receptors via a mechanism that does not require the coiled-coil domains.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15932871","citation_count":36,"is_preprint":false},{"pmid":"34684720","id":"PMC_34684720","title":"Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34684720","citation_count":34,"is_preprint":false},{"pmid":"27055476","id":"PMC_27055476","title":"Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes.","date":"2016","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27055476","citation_count":32,"is_preprint":false},{"pmid":"20522555","id":"PMC_20522555","title":"RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20522555","citation_count":30,"is_preprint":false},{"pmid":"23586521","id":"PMC_23586521","title":"RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation.","date":"2013","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23586521","citation_count":29,"is_preprint":false},{"pmid":"18471073","id":"PMC_18471073","title":"Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.","date":"2008","source":"Assay and drug development technologies","url":"https://pubmed.ncbi.nlm.nih.gov/18471073","citation_count":29,"is_preprint":false},{"pmid":"18179477","id":"PMC_18179477","title":"Molecular characterization and localization of the RIC-3 protein, an effector of nicotinic acetylcholine receptor expression.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18179477","citation_count":26,"is_preprint":false},{"pmid":"23638015","id":"PMC_23638015","title":"Chemical chaperones exceed the chaperone effects of RIC-3 in promoting assembly of functional α7 AChRs.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23638015","citation_count":26,"is_preprint":false},{"pmid":"27129882","id":"PMC_27129882","title":"RIC-3 expression and splicing regulate nAChR functional expression.","date":"2016","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/27129882","citation_count":22,"is_preprint":false},{"pmid":"23157401","id":"PMC_23157401","title":"Cell-specific effects on surface α7 nicotinic receptor expression revealed by over-expression and knockdown of rat RIC3 protein.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23157401","citation_count":20,"is_preprint":false},{"pmid":"17640815","id":"PMC_17640815","title":"Lack of RIC-3 congruence with beta2 subunit-containing nicotinic acetylcholine receptors in bipolar disorder.","date":"2007","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17640815","citation_count":20,"is_preprint":false},{"pmid":"17192664","id":"PMC_17192664","title":"Role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors.","date":"2006","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/17192664","citation_count":20,"is_preprint":false},{"pmid":"19899809","id":"PMC_19899809","title":"Receptor and subunit specific interactions of RIC-3 with nicotinic acetylcholine receptors.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19899809","citation_count":17,"is_preprint":false},{"pmid":"22970690","id":"PMC_22970690","title":"Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes.","date":"2012","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22970690","citation_count":17,"is_preprint":false},{"pmid":"19116311","id":"PMC_19116311","title":"The conserved RIC-3 coiled-coil domain mediates receptor-specific interactions with nicotinic acetylcholine receptors.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19116311","citation_count":17,"is_preprint":false},{"pmid":"19498422","id":"PMC_19498422","title":"Ric-3 chaperone-mediated stable cell-surface expression of the neuronal alpha7 nicotinic acetylcholine receptor in mammalian cells.","date":"2009","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/19498422","citation_count":16,"is_preprint":false},{"pmid":"19223395","id":"PMC_19223395","title":"The BTB-MATH protein BATH-42 interacts with RIC-3 to regulate maturation of nicotinic acetylcholine receptors.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19223395","citation_count":16,"is_preprint":false},{"pmid":"32179243","id":"PMC_32179243","title":"RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32179243","citation_count":14,"is_preprint":false},{"pmid":"32204458","id":"PMC_32204458","title":"Why Does Knocking Out NACHO, But Not RIC3, Completely Block Expression of α7 Nicotinic Receptors in Mouse Brain?","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32204458","citation_count":14,"is_preprint":false},{"pmid":"31870537","id":"PMC_31870537","title":"Delineating the Site of Interaction of the 5-HT3A Receptor with the Chaperone Protein RIC-3.","date":"2019","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31870537","citation_count":11,"is_preprint":false},{"pmid":"35889400","id":"PMC_35889400","title":"Speculation on How RIC-3 and Other Chaperones Facilitate α7 Nicotinic Receptor Folding and Assembly.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35889400","citation_count":10,"is_preprint":false},{"pmid":"18691158","id":"PMC_18691158","title":"Molecular cloning and characterization of a novel human variant of RIC-3, a putative chaperone of nicotinic acetylcholine receptors.","date":"2008","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/18691158","citation_count":10,"is_preprint":false},{"pmid":"27489343","id":"PMC_27489343","title":"RIC-3 phosphorylation enables dual regulation of excitation and inhibition of Caenorhabditis elegans muscle.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/27489343","citation_count":10,"is_preprint":false},{"pmid":"26258666","id":"PMC_26258666","title":"Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26258666","citation_count":9,"is_preprint":false},{"pmid":"36127041","id":"PMC_36127041","title":"Effects of cofactors RIC-3, TMX3 and UNC-50, together with distinct subunit ratios on the agonist actions of imidacloprid on Drosophila melanogaster Dα1/Dβ1 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.","date":"2022","source":"Pesticide biochemistry and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36127041","citation_count":8,"is_preprint":false},{"pmid":"37417463","id":"PMC_37417463","title":"Two residues determine nicotinic acetylcholine receptor requirement for RIC-3.","date":"2023","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/37417463","citation_count":5,"is_preprint":false},{"pmid":"28153381","id":"PMC_28153381","title":"RIC3 variants are not associated with Parkinson's disease in French-Canadians and French.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28153381","citation_count":5,"is_preprint":false},{"pmid":"39167025","id":"PMC_39167025","title":"Impact of a worker bee thoracic ganglion RIC-3 variant on the actions of acetylcholine and neonicotinoids on nicotinic receptors in Apis mellifera.","date":"2024","source":"Pest management science","url":"https://pubmed.ncbi.nlm.nih.gov/39167025","citation_count":5,"is_preprint":false},{"pmid":"29032010","id":"PMC_29032010","title":"Dual effects of insect nAChR chaperone RIC-3 on hybrid receptor: Promoting assembly on endoplasmic reticulum but suppressing transport to plasma membrane on Xenopus oocytes.","date":"2017","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/29032010","citation_count":4,"is_preprint":false},{"pmid":"38967800","id":"PMC_38967800","title":"N-Glycosylation Deficiency in Transgene α7 nAChR and RIC3 Expressing CHO Cells Without NACHO.","date":"2024","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/38967800","citation_count":3,"is_preprint":false},{"pmid":"28606768","id":"PMC_28606768","title":"Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.","date":"2017","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/28606768","citation_count":3,"is_preprint":false},{"pmid":"38472514","id":"PMC_38472514","title":"Unraveling the molecular interactions between α7 nicotinic receptor and a RIC3 variant associated with backward speech.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38472514","citation_count":2,"is_preprint":false},{"pmid":"36602087","id":"PMC_36602087","title":"Deletion induced splicing in RIC3 drives nicotinic acetylcholine receptor regulation with implications for endoplasmic reticulum stress in human astrocytes.","date":"2023","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/36602087","citation_count":2,"is_preprint":false},{"pmid":"37026993","id":"PMC_37026993","title":"Binding motif for RIC-3 chaperon protein in serotonin type 3A receptors.","date":"2023","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37026993","citation_count":2,"is_preprint":false},{"pmid":"41226195","id":"PMC_41226195","title":"Effects of Swapping 5HT3 and α7 Residues in Chimeric Receptor Proteins on RIC3 and NACHO Chaperone Actions.","date":"2025","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41226195","citation_count":1,"is_preprint":false},{"pmid":"23153976","id":"PMC_23153976","title":"Relationship of RIC-3 gene rs1528133 polymorphism with varying degrees of body weight and eating behavior.","date":"2012","source":"Diabetes & metabolic syndrome","url":"https://pubmed.ncbi.nlm.nih.gov/23153976","citation_count":1,"is_preprint":false},{"pmid":"41756857","id":"PMC_41756857","title":"RIC-3 Interacts Directly with the 5-HT3A Receptor to Mediate Trafficking Across Subcellular Compartments.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41756857","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27765,"output_tokens":7185,"usd":0.095535,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16342,"output_tokens":4312,"usd":0.094755,"stage2_stop_reason":"end_turn"},"total_usd":0.19029,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"C. elegans RIC-3 is specifically required for the maturation (folding/assembly and proper trafficking) of at least four nicotinic acetylcholine receptors (nAChRs), but not GABA or glutamate receptors expressed in the same cells. In ric-3 mutants, the DEG-3 receptor accumulates in the cell body rather than cell processes. Co-expression of ric-3 in Xenopus oocytes enhances activity of DEG-3/DES-2 and rat α7 nAChRs, demonstrating functional conservation.\",\n      \"method\": \"Genetic loss-of-function (C. elegans ric-3 mutants), immunolocalization, Xenopus oocyte co-expression electrophysiology\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vivo genetics, localization, heterologous expression), replicated in subsequent studies\",\n      \"pmids\": [\"11867529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human RIC-3 (hRIC-3) belongs to a conserved gene family (two transmembrane domains + coiled-coil domain) and differentially modulates human nAChRs: it enhances α7 nAChR currents but reduces α4β2 and α3β4 nAChR currents, and totally abolishes 5-HT3 receptor currents while barely affecting α1 glycine receptor currents in Xenopus oocytes. hRIC-3 produces multiple isoforms and is expressed in neurons and muscles.\",\n      \"method\": \"Xenopus oocyte co-expression with whole-cell current recording, RT-PCR/expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional electrophysiology across multiple receptor subtypes, independently replicated by subsequent papers\",\n      \"pmids\": [\"12821669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RIC-3 promotes formation of functional α7 nAChRs in mammalian HEK293 cells, as shown by whole-cell patch clamp and surface α-bungarotoxin binding. α7 and RIC-3 proteins co-associate by co-immunoprecipitation. RIC-3 enables α-bungarotoxin surface labeling even though α7 protein reaches the plasma membrane without RIC-3, indicating RIC-3 is required for proper folding/assembly (not merely trafficking) of α7 receptors.\",\n      \"method\": \"Whole-cell patch clamp, surface biotinylation, α-bungarotoxin binding, co-immunoprecipitation in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional and biochemical evidence in mammalian cells, replicated across labs\",\n      \"pmids\": [\"15504725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RIC-3 enhances functional expression of multiple homomeric (α7, α8) nAChR subtypes in transfected mammalian cells. Unlike in Xenopus oocytes, RIC-3 also enhances heteromeric nAChRs (α3β2, α3β4, α4β2, α4β4) in mammalian cells. Co-immunoprecipitation demonstrates RIC-3 associates with unassembled nAChR subunits (α3, α4, α7, β2, β4), consistent with a role in promoting subunit folding and assembly.\",\n      \"method\": \"Radioligand binding, patch clamp electrophysiology, co-immunoprecipitation from metabolically labeled transfected mammalian cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple receptor subtypes, orthogonal methods (binding + function + co-IP), independently replicated\",\n      \"pmids\": [\"16120769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"hRIC-3 inhibits surface expression of α4β2 nAChRs and 5-HT3 receptors by blocking export of mature receptors to the cell membrane, whereas it enhances α7 nAChR expression by increasing the number of mature receptors and facilitating membrane transport. The N-terminal region (two TM segments) and C-terminal region are both required for these differential effects. A specific extracellular isoleucine near the first TM domain of 5-HT3/α4β2 receptors mediates the transport arrest induced by hRIC-3. Specific amino acids in the amphipathic helix of the large cytoplasmic domain of α7 are required for enhancement.\",\n      \"method\": \"Chimeric receptor co-expression, site-directed mutagenesis, co-immunoprecipitation, confocal microscopy in Xenopus oocytes and mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of specific residues combined with functional and trafficking assays, multiple orthogonal approaches\",\n      \"pmids\": [\"15927954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RIC-3 is localized to the endoplasmic reticulum (co-localization with BiP). RIC-3 enhances surface transport and function of 5-HT3A receptors in a concentration-dependent manner. The interaction between RIC-3 and 5-HT3A is transient (<4 h). RIC-3 can interact with an ER-retained 5-HT3A construct, suggesting a role in folding/assembly rather than later trafficking steps. RIC-3 is not detected at significant levels on the cell surface.\",\n      \"method\": \"Confocal co-localization with BiP (ER marker), co-immunoprecipitation time course, surface expression assays in mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct co-IP evidence for transient interaction, ER localization confirmed biochemically and by co-localization, multiple orthogonal methods\",\n      \"pmids\": [\"15809299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RIC-3 effects on DEG-3/DES-2 nAChR functional expression and receptor kinetics/agonist affinity are mediated by the transmembrane domains and do not require the coiled-coil domains. RIC-3 preferentially promotes maturation of DEG-3-rich receptors, affecting the subunit composition of assembled receptors. RIC-3 also stabilizes receptor intermediates (affects DEG-3 quantity).\",\n      \"method\": \"Xenopus oocyte co-expression electrophysiology, deletion/domain-swap mutagenesis, receptor subunit ratio manipulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — domain mutagenesis with functional readout, multiple receptor ratios tested, single lab\",\n      \"pmids\": [\"15932871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human RIC-3 isoform a (RIC-3a) is targeted to the ER by an N-terminal signal sequence and forms diffuse reticular and halo structures; it is highly mobile within the ER. RIC-3a enhances surface expression of homomeric 5-HT3A receptors but inhibits surface expression of heteromeric 5-HT3A/B receptors. A truncated isoform (RIC-3d), lacking the large coiled-coil C-terminal domain, localizes to ER and cycles between ER and Golgi, does not aggregate, yet retains the ability to enhance homomeric and inhibit heteromeric 5-HT3 receptor surface expression.\",\n      \"method\": \"Fluorescence live imaging (FRAP), confocal co-localization, flow cytometry surface expression assays in mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with FRAP, subcellular fractionation, multiple receptor readouts, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"17609200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"hRIC-3 membrane topology: in vitro translation showed membrane insertion but the first TM domain does not act as a signal peptide. Substitution of both TM domains attenuates effects on nAChR expression. A minimum linker length between TM domains is needed for α7 enhancement but not for α4β2 inhibition. A combination of increased α7 steady-state levels, facilitated transport, and reduced receptor internalization accounts for hRIC-3-mediated enhancement of α7 membrane expression. RIC-3 is expressed in SH-SY5Y and PC12 cells and is induced upon differentiation; immunohistochemistry localizes it to rat brain regions co-expressing α7 nAChRs.\",\n      \"method\": \"In vitro translation/membrane insertion assay, TM domain substitution mutagenesis, immunohistochemistry, Western blot\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with functional assays and localization, single lab\",\n      \"pmids\": [\"18179477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The coiled-coil domain (CC-I) of C. elegans RIC-3 mediates receptor-specific interactions: it promotes maturation of specific nAChRs expressed in body-wall muscle but is dispensable for other nAChR subtypes. Co-immunoprecipitation confirms CC-I enhances RIC-3 affinity for specific nAChRs. Alternative splicing generates RIC-3 isoforms lacking CC-I or the entire C-terminus, enabling subtype-specific regulation.\",\n      \"method\": \"In vivo C. elegans deletion mutant analysis, co-immunoprecipitation, Xenopus oocyte heterologous expression electrophysiology\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetics combined with co-IP and heterologous expression, multiple receptor subtypes tested\",\n      \"pmids\": [\"19116311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Drosophila RIC-3 nAChR chaperone activity does not require the coiled-coil domain (encoded by exon 7). An extra exon (exon 2) within a proline-rich N-terminal region greatly reduces chaperone activity. Host-cell-specific factors modulate RIC-3 chaperone efficiency: DmRIC-3 is more efficient in Drosophila cells, whereas human RIC-3 is more efficient in human cells, indicating cell-type-specific modulatory proteins.\",\n      \"method\": \"Cloning of 11 alternative splice isoforms, co-expression electrophysiology in Drosophila and human cell lines\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional comparison across isoforms and cell types, single lab, single functional readout\",\n      \"pmids\": [\"18208544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mouse RIC-3 is targeted to the ER by a cleavable N-terminal signal sequence (first 31 aa). The mature protein is a single-pass type I transmembrane protein with the N-terminus in the ER lumen and the coiled-coil domain in the cytoplasm. RIC-3 binds both unfolded and folded α7 subunits. The coiled-coil domain is required for homotypic self-association of RIC-3 molecules, which is necessary for efficient α7 assembly, but the coiled-coil is not required for RIC-3–α7 interaction itself. The lumenal segment and the coiled-coil domain (but not the long C-terminal tail) are required for facilitating α7 surface expression.\",\n      \"method\": \"Signal sequence analysis, protease protection/topology assay, co-immunoprecipitation, deletion/domain mutagenesis, surface expression assays in mammalian cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — topology determination, mutagenesis of multiple domains, binding to folded vs unfolded subunits distinguished, multiple orthogonal assays\",\n      \"pmids\": [\"19812337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BATH-42, a BTB-MATH domain-containing protein, interacts with RIC-3 (shown in yeast two-hybrid and in vitro). BATH-42 also interacts with the CUL-3 ubiquitin ligase complex. Loss of BATH-42 increases RIC-3 expression and decreases nAChR activity; overexpression of BATH-42 is also detrimental in a CUL-3-dependent and RIC-3 C-terminus-dependent manner. The data indicate BATH-42 targets RIC-3 for degradation via CUL-3-mediated ubiquitylation, thereby regulating RIC-3 levels.\",\n      \"method\": \"Yeast two-hybrid, in vitro interaction assay, C. elegans genetic loss-of-function/overexpression, electrophysiology\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vitro interaction plus in vivo genetic epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"19223395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Conserved residues in the second RIC-3 transmembrane domain are required for interactions with DEG-3/DES-2 and ACR-16 nAChRs, but additional domains also contribute. The relative contribution of the second TM domain vs. other domains differs between the two receptors, suggesting RIC-3 (predicted intrinsically disordered) adopts different conformations to interact with different receptors/subunits.\",\n      \"method\": \"Co-immunoprecipitation with domain deletion/point mutants in C. elegans and Xenopus oocytes, surface expression assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with co-IP and functional assays, single lab\",\n      \"pmids\": [\"19899809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ric-3 can promote OR inhibit cell-surface delivery of α7 nAChRs (BgtRs) depending on expression level. At low levels, Ric-3 promotes α7 assembly, ER release, and surface delivery without trafficking from the ER itself. At high levels, Ric-3 suppresses surface delivery but not assembly, retaining BgtRs in the ER or in Ric-3-containing aggregates. In neurons, Ric-3 and α7 subunits are restricted to somata and dendrites (not axons) of inhibitory interneurons; Ric-3 traffics with α7 in vesicles to dendrites where it is restricted to the ER subcompartment, suggesting ER retention promotes dendritic transport.\",\n      \"method\": \"PC12 and cultured neuron live imaging, immunolocalization, co-trafficking experiments, surface BgtR binding assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging in neurons with trafficking analysis, multiple cell types, functional and localization readouts combined\",\n      \"pmids\": [\"20668195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RIC-3 directly interacts with 5-HT3A, -C, -D, and -E subunits (co-localization in ER and co-immunoprecipitation), but exclusively enhances surface expression of homomeric 5-HT3A receptors in HEK293 cells. Increases in functional response (Emax) correlate with increased surface receptor levels (Bmax for [3H]GR65630 binding) and increased surface 5-HT3A as measured by flow cytometry.\",\n      \"method\": \"Co-immunoprecipitation, co-localization by immunocytochemistry, Ca2+ influx assays, radioligand binding, flow cytometry in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP interaction with multiple subunits combined with functional assays and flow cytometry, multiple orthogonal methods\",\n      \"pmids\": [\"20522555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RIC-3 increases assembly and cell-surface trafficking of α7 receptors but does not alter α7 protein expression levels in HEK293T cells. In contrast, RIC-3 does not affect α4β2 receptor assembly but increases α4 and β2 subunit protein expression. When co-expressed with α4β2 receptors, RIC-3 prevents nicotine-induced upregulation of α4β2 receptors (assessed by FRET between subunits).\",\n      \"method\": \"FRET microscopy with fluorescent protein-tagged subunits, surface trafficking assays in HEK293T cells\",\n      \"journal\": \"BMC neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET-based assembly measurement, single lab, two receptor subtypes compared\",\n      \"pmids\": [\"23586521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Phosphorylation of RIC-3 at Ser-164 in C. elegans increases muscle excitability. This phosphorylation is regulated by the phosphatase calcineurin (TAX-6) and casein kinase II homologue KIN-10. Effects of calcineurin downregulation and phosphorylated RIC-3 on excitability are mediated by GABAA receptor inhibition. Thus, phosphorylated RIC-3 influences not only nAChRs but also GABAA receptors, enabling coordinated regulation of excitation-inhibition balance.\",\n      \"method\": \"C. elegans in vivo phosphorylation analysis, genetic epistasis with calcineurin and casein kinase II mutants, electrophysiology\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetics with epistasis and specific phosphorylation site identified, single lab\",\n      \"pmids\": [\"27489343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RIC-3 expression level and splicing (generating multiple conserved isoforms) affect nAChR functional expression in brain and immune cells. In immune cells, RIC-3 expression and splicing are dynamically regulated by inflammatory signals. siRNA-mediated silencing of RIC3 in mouse macrophages eliminates the anti-inflammatory effects of cholinergic agonists, placing RIC3 as required for functional α7 nAChR-mediated cholinergic anti-inflammatory signaling.\",\n      \"method\": \"In situ hybridization, qRT-PCR, Xenopus oocyte electrophysiology, siRNA knockdown in macrophages with functional anti-inflammatory readout\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with specific functional readout in immune cells, combined with expression analysis, single lab\",\n      \"pmids\": [\"27129882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Two RIC3 missense variants (P57T and V168L) identified in Parkinson's disease patients act as dominant negatives in PC12 cells: they reduce endogenous CHRNA7 (α7 nAChR subunit) levels in membrane fractions and decrease co-localization profiles compared to wild-type RIC3, suggesting impaired chaperone-mediated receptor trafficking to the plasma membrane.\",\n      \"method\": \"Transfection of mutant RIC3 in differentiated PC12 cells, Western blot of membrane fractions, confocal co-localization\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based dominant negative assay with biochemical and imaging readouts, single lab\",\n      \"pmids\": [\"27055476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The intracellular domain (ICD) of 5-HT3A is required for its interaction with RIC-3. A 24-amino-acid-long segment within the 5-HT3A ICD is the molecular determinant for the RIC-3–5-HT3A interaction, identified using MBP-fused ICD deletion constructs in a RIC-3 affinity pull-down assay.\",\n      \"method\": \"Recombinant MBP-fused 5-HT3A ICD deletion constructs, RIC-3 affinity pull-down assay with purified proteins\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro pull-down with purified recombinant proteins and deletion constructs, single lab\",\n      \"pmids\": [\"31870537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Two residues in nematode ACR-16 nAChR (R/K159 in the cys-loop and I504 in the C-terminal tail) account for the receptor's requirement for RIC-3 in functional expression. Mutating either residue in a non-RIC-3-requiring ACR-16 (from Dracunculus medinensis) to residues found in RIC-3-requiring orthologs confers a RIC-3 requirement, demonstrating these receptor residues mediate the functional dependency on RIC-3.\",\n      \"method\": \"Chimeric receptor construction, point mutagenesis, electrophysiology in Xenopus oocytes\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reciprocal mutagenesis in chimeric receptors with gain-of-function phenotype, electrophysiological readout, single lab\",\n      \"pmids\": [\"37417463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The RIC-3 binding motif in 5-HT3A is a duplicated sequence (DWLR…VLDR) present in both the MX-helix and the transition between the ICD MA-helix and TM segment M4. Key residues W347, R349, L353 (MX-helix) and W447, R449, L454 (MAM4 transition) are critical for RIC-3 interaction. Alanine substitutions at these positions disrupt both peptide-based and full-length 5-HT3A–RIC-3 interactions and reduce RIC-3-mediated enhancement of functional surface expression.\",\n      \"method\": \"Ala-scanning mutagenesis with synthetic peptides in pull-down assay, full-length receptor mutagenesis with surface expression functional assays\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic Ala-scanning of binding motif validated in both peptide and full-length receptor contexts, single lab\",\n      \"pmids\": [\"37026993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A RIC3 variant G88R associated with exceptional backward speech decreases both cell-surface expression and functional expression of α7 nAChRs compared to wild-type RIC3. FRET analysis shows that RIC3-G88R increases interactions between RIC3 and α7 protein in the ER, suggesting excessive or prolonged ER retention underlies reduced surface expression.\",\n      \"method\": \"FRET microscopy with fluorescent protein-tagged α7 nAChR, 125I-α-bungarotoxin binding, functional assays in HEK cells\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET combined with binding and functional assays, single lab, single variant studied\",\n      \"pmids\": [\"38472514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"RIC-3 directly interacts with the 5-HT3A intracellular domain (ICD) in native cellular contexts: a recombinant 5-HT3A ICD peptide specifically pulls down RIC-3 from Xenopus oocyte plasma membrane fractions, SH-SY5Y cell ER fractions, and mouse brain tissue. RIC-3 knockdown in SH-SY5Y cells reduces both this peptide binding and surface levels of nAChR-α7 and 5-HT3A receptors.\",\n      \"method\": \"Peptide-resin pull-down assay from native tissue and cell fractions, RIC-3 siRNA knockdown with surface receptor quantification\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pull-down from native contexts is compelling but preprint, single lab, not yet peer-reviewed\",\n      \"pmids\": [\"41756857\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"RIC-3 is an ER-resident single-pass transmembrane protein (with a cleavable signal sequence directing its N-terminus into the ER lumen and a cytoplasmic coiled-coil domain) that acts as a subtype-specific molecular chaperone for pentameric ligand-gated ion channels: at physiological levels it transiently binds unassembled nAChR and 5-HT3 receptor subunits via its transmembrane domains and specific receptor ICD motifs (including a duplicated DWLR/VLDR motif in 5-HT3A), promoting subunit folding, oligomeric assembly, and ER export primarily for homomeric α7 nAChRs and homomeric 5-HT3A receptors, while retaining or inhibiting maturation of heteromeric subtypes (α4β2, α3β4, 5-HT3A/B); its chaperone activity is dose-dependent (high levels cause ER retention), regulated by CUL-3-mediated ubiquitylation (via BATH-42) and by phosphorylation at Ser-164 (controlled by calcineurin/casein kinase II balance), and modulated by alternative splicing that generates isoforms with differential subcellular distributions and receptor-subtype specificities.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RIC-3 is an endoplasmic reticulum-resident transmembrane chaperone that controls the folding, assembly, and surface delivery of pentameric ligand-gated ion channels, principally nicotinic acetylcholine receptors (nAChRs) and 5-HT3 receptors [#0, #1, #5]. Identified in C. elegans as specifically required for maturation of multiple nAChRs but not GABA or glutamate receptors [#0], it acts subtype-selectively: it enhances functional expression of homomeric receptors such as \\u03b17, \\u03b18, and homomeric 5-HT3A, while inhibiting or retaining heteromeric subtypes including \\u03b14\\u03b22, \\u03b13\\u03b24, and 5-HT3A/B [#1, #3, #7, #15]. Co-immunoprecipitation establishes that RIC-3 transiently and directly binds unassembled receptor subunits in the ER to promote proper folding and oligomeric assembly rather than acting only at later trafficking steps [#2, #3, #5]. Topologically it is a single-pass type I transmembrane protein with a cleavable N-terminal signal sequence placing its N-terminus in the ER lumen and its coiled-coil domain in the cytoplasm; the transmembrane domains mediate receptor binding, while coiled-coil-dependent self-association drives efficient \\u03b17 assembly [#11, #13]. Receptor specificity is encoded on both partners: RIC-3 recognizes intracellular-domain motifs in 5-HT3A\\u2014a duplicated DWLR/VLDR sequence in the MX-helix and MA-helix/M4 transition [#20, #22]\\u2014and discrete receptor residues (e.g., in ACR-16) dictate the dependency on RIC-3 [#21]. RIC-3 chaperone activity is dose-dependent, switching from promoting surface delivery at low levels to ER retention and aggregation at high levels [#14], and is further controlled by CUL-3/BATH-42-mediated ubiquitylation that sets RIC-3 protein levels [#12] and by Ser-164 phosphorylation under calcineurin/casein kinase II control, which extends its influence to excitation-inhibition balance via GABAA receptors [#17]. Functionally, RIC-3 is required for \\u03b17 nAChR-mediated cholinergic anti-inflammatory signaling in macrophages [#18], and RIC3 missense variants that impair \\u03b17 trafficking have been linked to Parkinson's disease and to an exceptional-backward-speech phenotype [#19, #23].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established RIC-3 as a dedicated maturation factor for nAChRs, answering whether a specific accessory protein governs nicotinic receptor biogenesis distinct from other ionotropic receptors.\",\n      \"evidence\": \"C. elegans ric-3 loss-of-function genetics, immunolocalization of DEG-3, and Xenopus oocyte co-expression electrophysiology\",\n      \"pmids\": [\"11867529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular mechanism of action (folding vs trafficking)\", \"Did not establish subcellular site of action\", \"Mammalian receptor scope untested at this stage\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that the human ortholog is subtype-selective, showing RIC-3 can enhance some channels (\\u03b17) while suppressing others (\\u03b14\\u03b22, \\u03b13\\u03b24, 5-HT3), establishing differential modulation as a core feature.\",\n      \"evidence\": \"Xenopus oocyte co-expression whole-cell recording across multiple receptor subtypes plus expression analysis\",\n      \"pmids\": [\"12821669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of opposite effects on different subtypes unexplained\", \"Domain requirements undefined\", \"Oocyte results later found to differ from mammalian cells\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed RIC-3 physically associates with \\u03b17 and is required for folding/assembly rather than mere trafficking, since \\u03b17 reaches the surface without RIC-3 but is not functional.\",\n      \"evidence\": \"Whole-cell patch clamp, surface biotinylation, \\u03b1-bungarotoxin binding and co-immunoprecipitation in HEK293 cells\",\n      \"pmids\": [\"15504725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the interacting domains\", \"Stoichiometry and transience of binding unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Localized RIC-3 to the ER and defined its action as transient binding to unassembled/ER-retained subunits, fixing the cellular site and timing of chaperone activity; also mapped which receptor and RIC-3 regions drive enhancement vs transport arrest.\",\n      \"evidence\": \"BiP co-localization, co-IP time courses, chimeric receptor and site-directed mutagenesis, and domain analyses in mammalian cells and oocytes\",\n      \"pmids\": [\"15809299\", \"15927954\", \"16120769\", \"15932871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise binding motifs not yet defined\", \"Membrane topology not established\", \"Discrepancy between oocyte and mammalian heteromer effects unexplained\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved RIC-3 membrane topology and the division of labor among its domains, establishing that TM domains mediate receptor binding while the coiled-coil drives self-association required for efficient \\u03b17 assembly.\",\n      \"evidence\": \"Signal-sequence and protease-protection topology assays, deletion/domain mutagenesis, and co-IP distinguishing folded vs unfolded \\u03b17 binding in mammalian cells\",\n      \"pmids\": [\"19812337\", \"19116311\", \"19899809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational basis for binding diverse receptors not structurally defined\", \"Self-association stoichiometry unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified post-translational control of RIC-3 abundance, showing BATH-42 links RIC-3 to CUL-3-mediated ubiquitylation and degradation to tune chaperone levels.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro interaction, and C. elegans genetic epistasis with electrophysiology\",\n      \"pmids\": [\"19223395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitylation sites on RIC-3 not mapped\", \"Conservation of this regulation in mammals untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that RIC-3 effects are concentration-dependent, switching from promoting surface delivery at low levels to ER retention/aggregation at high levels, reconciling its dual enhancing/inhibitory behavior.\",\n      \"evidence\": \"Live imaging and co-trafficking in PC12 cells and neurons with surface \\u03b1-bungarotoxin binding\",\n      \"pmids\": [\"20668195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological control of RIC-3 dosage in vivo unclear\", \"Relationship of aggregation to dendritic targeting mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended RIC-3 regulation to phosphorylation, showing Ser-164 phosphorylation under calcineurin/CKII control modulates excitability and broadens its influence to GABAA receptors.\",\n      \"evidence\": \"C. elegans in vivo phosphorylation analysis and genetic epistasis with electrophysiology\",\n      \"pmids\": [\"27489343\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphorylation of RIC-3 by these kinases not biochemically shown\", \"Mammalian conservation of Ser-164 regulation untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked RIC-3 to physiological cholinergic signaling beyond neurons, establishing it as required for \\u03b17 nAChR-mediated anti-inflammatory responses in immune cells.\",\n      \"evidence\": \"siRNA knockdown in macrophages with cholinergic anti-inflammatory functional readout plus expression/splicing analysis\",\n      \"pmids\": [\"27129882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of inflammatory regulation of RIC3 splicing unresolved\", \"Single functional readout\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapped the 5-HT3A determinant of RIC-3 binding to a discrete 24-residue intracellular-domain segment, moving receptor recognition from region-level to motif-level resolution.\",\n      \"evidence\": \"MBP-fused ICD deletion constructs in RIC-3 affinity pull-down with purified proteins\",\n      \"pmids\": [\"31870537\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Performed with purified fragments rather than full-length receptor in cells\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined RIC-3 recognition on both partners at residue resolution: a duplicated DWLR/VLDR motif in the 5-HT3A ICD and specific ACR-16 residues that confer dependency on RIC-3.\",\n      \"evidence\": \"Ala-scanning of synthetic peptides and full-length receptors with functional surface assays; reciprocal chimeric/point mutagenesis with oocyte electrophysiology\",\n      \"pmids\": [\"37026993\", \"37417463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the RIC-3\\u2013receptor complex not solved\", \"Whether the same motifs govern nAChR binding broadly untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected RIC3 sequence variation to human phenotypes, showing disease-associated variants impair \\u03b17 surface delivery through aberrant ER retention or dominant-negative trafficking defects.\",\n      \"evidence\": \"FRET, 125I-\\u03b1-bungarotoxin binding, and functional assays of variant RIC3 in PC12/HEK cells\",\n      \"pmids\": [\"38472514\", \"27055476\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causality in patients not established by family/rescue studies in the corpus\", \"Single variants studied per phenotype\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RIC-3 structurally accommodates and discriminates among diverse receptor subunits to produce opposite (enhancing vs retaining) outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of a RIC-3\\u2013receptor complex\", \"Molecular basis for subtype-selective enhancement vs retention unexplained\", \"Mammalian counterparts of BATH-42/CUL-3 and Ser-164 regulation not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 2, 3, 5, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 7, 11, 14]},\n      {\"term_id\": \"GO:0005789\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 3, 5, 11]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [4, 14, 15]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 8, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CHRNA7\", \"HTR3A\", \"BATH-42\", \"CUL-3\", \"CHRNB2\", \"CHRNA4\", \"DEG-3\", \"ACR-16\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}